Global Drug–Device Combination Products Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
LPI (LP Information)' newest research report, the “Drug–Device Combination Products Industry Forecast” looks at past sales and reviews total world Drug–Device Combination Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug–Device Combination Products sales for 2023 through 2029. With Drug–Device Combination Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug–Device Combination Products industry.
This Insight Report provides a comprehensive analysis of the global Drug–Device Combination Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug–Device Combination Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug–Device Combination Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug–Device Combination Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug–Device Combination Products.
The global Drug–Device Combination Products market size is projected to grow from US$ 34430 million in 2022 to US$ 50080 million in 2029; it is expected to grow at a CAGR of 50080 from 2023 to 2029.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug–Device Combination Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Drug–Device Combination Products market?
What factors are driving Drug–Device Combination Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug–Device Combination Products market opportunities vary by end market size?
How does Drug–Device Combination Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
LPI (LP Information)' newest research report, the “Drug–Device Combination Products Industry Forecast” looks at past sales and reviews total world Drug–Device Combination Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug–Device Combination Products sales for 2023 through 2029. With Drug–Device Combination Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug–Device Combination Products industry.
This Insight Report provides a comprehensive analysis of the global Drug–Device Combination Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug–Device Combination Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug–Device Combination Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug–Device Combination Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug–Device Combination Products.
The global Drug–Device Combination Products market size is projected to grow from US$ 34430 million in 2022 to US$ 50080 million in 2029; it is expected to grow at a CAGR of 50080 from 2023 to 2029.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug–Device Combination Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Infusion Pumps
- Orthopedic Combination Products
- Photodynamic Therapy Devices
- Transdermal Patches
- Drug Eluting Stents
- Wound Care Products
- Inhalers
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Terumo Corporation
- Stryker Corporation
- Mylan
- Medtronic
- Allergan
- Boston Scientific
- Novartis
- BD
- Teleflex Incorporated
What is the 10-year outlook for the global Drug–Device Combination Products market?
What factors are driving Drug–Device Combination Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug–Device Combination Products market opportunities vary by end market size?
How does Drug–Device Combination Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug–Device Combination Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug–Device Combination Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug–Device Combination Products by Country/Region, 2018, 2022 & 2029
2.2 Drug–Device Combination Products Segment by Type
2.2.1 Infusion Pumps
2.2.2 Orthopedic Combination Products
2.2.3 Photodynamic Therapy Devices
2.2.4 Transdermal Patches
2.2.5 Drug Eluting Stents
2.2.6 Wound Care Products
2.2.7 Inhalers
2.2.8 Other
2.3 Drug–Device Combination Products Sales by Type
2.3.1 Global Drug–Device Combination Products Sales Market Share by Type (2018-2023)
2.3.2 Global Drug–Device Combination Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug–Device Combination Products Sale Price by Type (2018-2023)
2.4 Drug–Device Combination Products Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Drug–Device Combination Products Sales by Application
2.5.1 Global Drug–Device Combination Products Sale Market Share by Application (2018-2023)
2.5.2 Global Drug–Device Combination Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug–Device Combination Products Sale Price by Application (2018-2023)
3 GLOBAL DRUG–DEVICE COMBINATION PRODUCTS BY COMPANY
3.1 Global Drug–Device Combination Products Breakdown Data by Company
3.1.1 Global Drug–Device Combination Products Annual Sales by Company (2018-2023)
3.1.2 Global Drug–Device Combination Products Sales Market Share by Company (2018-2023)
3.2 Global Drug–Device Combination Products Annual Revenue by Company (2018-2023)
3.2.1 Global Drug–Device Combination Products Revenue by Company (2018-2023)
3.2.2 Global Drug–Device Combination Products Revenue Market Share by Company (2018-2023)
3.3 Global Drug–Device Combination Products Sale Price by Company
3.4 Key Manufacturers Drug–Device Combination Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug–Device Combination Products Product Location Distribution
3.4.2 Players Drug–Device Combination Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG–DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Drug–Device Combination Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug–Device Combination Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug–Device Combination Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug–Device Combination Products Market Size by Country/Region (2018-2023)
4.2.1 Global Drug–Device Combination Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug–Device Combination Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug–Device Combination Products Sales Growth
4.4 APAC Drug–Device Combination Products Sales Growth
4.5 Europe Drug–Device Combination Products Sales Growth
4.6 Middle East & Africa Drug–Device Combination Products Sales Growth
5 AMERICAS
5.1 Americas Drug–Device Combination Products Sales by Country
5.1.1 Americas Drug–Device Combination Products Sales by Country (2018-2023)
5.1.2 Americas Drug–Device Combination Products Revenue by Country (2018-2023)
5.2 Americas Drug–Device Combination Products Sales by Type
5.3 Americas Drug–Device Combination Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug–Device Combination Products Sales by Region
6.1.1 APAC Drug–Device Combination Products Sales by Region (2018-2023)
6.1.2 APAC Drug–Device Combination Products Revenue by Region (2018-2023)
6.2 APAC Drug–Device Combination Products Sales by Type
6.3 APAC Drug–Device Combination Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug–Device Combination Products by Country
7.1.1 Europe Drug–Device Combination Products Sales by Country (2018-2023)
7.1.2 Europe Drug–Device Combination Products Revenue by Country (2018-2023)
7.2 Europe Drug–Device Combination Products Sales by Type
7.3 Europe Drug–Device Combination Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug–Device Combination Products by Country
8.1.1 Middle East & Africa Drug–Device Combination Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug–Device Combination Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug–Device Combination Products Sales by Type
8.3 Middle East & Africa Drug–Device Combination Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug–Device Combination Products
10.3 Manufacturing Process Analysis of Drug–Device Combination Products
10.4 Industry Chain Structure of Drug–Device Combination Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug–Device Combination Products Distributors
11.3 Drug–Device Combination Products Customer
12 WORLD FORECAST REVIEW FOR DRUG–DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Drug–Device Combination Products Market Size Forecast by Region
12.1.1 Global Drug–Device Combination Products Forecast by Region (2024-2029)
12.1.2 Global Drug–Device Combination Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug–Device Combination Products Forecast by Type
12.7 Global Drug–Device Combination Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Drug–Device Combination Products Product Portfolios and Specifications
13.1.3 Abbott Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Terumo Corporation
13.2.1 Terumo Corporation Company Information
13.2.2 Terumo Corporation Drug–Device Combination Products Product Portfolios and Specifications
13.2.3 Terumo Corporation Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Terumo Corporation Main Business Overview
13.2.5 Terumo Corporation Latest Developments
13.3 Stryker Corporation
13.3.1 Stryker Corporation Company Information
13.3.2 Stryker Corporation Drug–Device Combination Products Product Portfolios and Specifications
13.3.3 Stryker Corporation Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Stryker Corporation Main Business Overview
13.3.5 Stryker Corporation Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Drug–Device Combination Products Product Portfolios and Specifications
13.4.3 Mylan Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Medtronic
13.5.1 Medtronic Company Information
13.5.2 Medtronic Drug–Device Combination Products Product Portfolios and Specifications
13.5.3 Medtronic Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Medtronic Main Business Overview
13.5.5 Medtronic Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Drug–Device Combination Products Product Portfolios and Specifications
13.6.3 Allergan Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Boston Scientific
13.7.1 Boston Scientific Company Information
13.7.2 Boston Scientific Drug–Device Combination Products Product Portfolios and Specifications
13.7.3 Boston Scientific Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boston Scientific Main Business Overview
13.7.5 Boston Scientific Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Drug–Device Combination Products Product Portfolios and Specifications
13.8.3 Novartis Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 BD
13.9.1 BD Company Information
13.9.2 BD Drug–Device Combination Products Product Portfolios and Specifications
13.9.3 BD Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BD Main Business Overview
13.9.5 BD Latest Developments
13.10 Teleflex Incorporated
13.10.1 Teleflex Incorporated Company Information
13.10.2 Teleflex Incorporated Drug–Device Combination Products Product Portfolios and Specifications
13.10.3 Teleflex Incorporated Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teleflex Incorporated Main Business Overview
13.10.5 Teleflex Incorporated Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug–Device Combination Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug–Device Combination Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug–Device Combination Products by Country/Region, 2018, 2022 & 2029
2.2 Drug–Device Combination Products Segment by Type
2.2.1 Infusion Pumps
2.2.2 Orthopedic Combination Products
2.2.3 Photodynamic Therapy Devices
2.2.4 Transdermal Patches
2.2.5 Drug Eluting Stents
2.2.6 Wound Care Products
2.2.7 Inhalers
2.2.8 Other
2.3 Drug–Device Combination Products Sales by Type
2.3.1 Global Drug–Device Combination Products Sales Market Share by Type (2018-2023)
2.3.2 Global Drug–Device Combination Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug–Device Combination Products Sale Price by Type (2018-2023)
2.4 Drug–Device Combination Products Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Drug–Device Combination Products Sales by Application
2.5.1 Global Drug–Device Combination Products Sale Market Share by Application (2018-2023)
2.5.2 Global Drug–Device Combination Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug–Device Combination Products Sale Price by Application (2018-2023)
3 GLOBAL DRUG–DEVICE COMBINATION PRODUCTS BY COMPANY
3.1 Global Drug–Device Combination Products Breakdown Data by Company
3.1.1 Global Drug–Device Combination Products Annual Sales by Company (2018-2023)
3.1.2 Global Drug–Device Combination Products Sales Market Share by Company (2018-2023)
3.2 Global Drug–Device Combination Products Annual Revenue by Company (2018-2023)
3.2.1 Global Drug–Device Combination Products Revenue by Company (2018-2023)
3.2.2 Global Drug–Device Combination Products Revenue Market Share by Company (2018-2023)
3.3 Global Drug–Device Combination Products Sale Price by Company
3.4 Key Manufacturers Drug–Device Combination Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug–Device Combination Products Product Location Distribution
3.4.2 Players Drug–Device Combination Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG–DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Drug–Device Combination Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug–Device Combination Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug–Device Combination Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug–Device Combination Products Market Size by Country/Region (2018-2023)
4.2.1 Global Drug–Device Combination Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug–Device Combination Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug–Device Combination Products Sales Growth
4.4 APAC Drug–Device Combination Products Sales Growth
4.5 Europe Drug–Device Combination Products Sales Growth
4.6 Middle East & Africa Drug–Device Combination Products Sales Growth
5 AMERICAS
5.1 Americas Drug–Device Combination Products Sales by Country
5.1.1 Americas Drug–Device Combination Products Sales by Country (2018-2023)
5.1.2 Americas Drug–Device Combination Products Revenue by Country (2018-2023)
5.2 Americas Drug–Device Combination Products Sales by Type
5.3 Americas Drug–Device Combination Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug–Device Combination Products Sales by Region
6.1.1 APAC Drug–Device Combination Products Sales by Region (2018-2023)
6.1.2 APAC Drug–Device Combination Products Revenue by Region (2018-2023)
6.2 APAC Drug–Device Combination Products Sales by Type
6.3 APAC Drug–Device Combination Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug–Device Combination Products by Country
7.1.1 Europe Drug–Device Combination Products Sales by Country (2018-2023)
7.1.2 Europe Drug–Device Combination Products Revenue by Country (2018-2023)
7.2 Europe Drug–Device Combination Products Sales by Type
7.3 Europe Drug–Device Combination Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug–Device Combination Products by Country
8.1.1 Middle East & Africa Drug–Device Combination Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug–Device Combination Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug–Device Combination Products Sales by Type
8.3 Middle East & Africa Drug–Device Combination Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug–Device Combination Products
10.3 Manufacturing Process Analysis of Drug–Device Combination Products
10.4 Industry Chain Structure of Drug–Device Combination Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug–Device Combination Products Distributors
11.3 Drug–Device Combination Products Customer
12 WORLD FORECAST REVIEW FOR DRUG–DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Drug–Device Combination Products Market Size Forecast by Region
12.1.1 Global Drug–Device Combination Products Forecast by Region (2024-2029)
12.1.2 Global Drug–Device Combination Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug–Device Combination Products Forecast by Type
12.7 Global Drug–Device Combination Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Drug–Device Combination Products Product Portfolios and Specifications
13.1.3 Abbott Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Terumo Corporation
13.2.1 Terumo Corporation Company Information
13.2.2 Terumo Corporation Drug–Device Combination Products Product Portfolios and Specifications
13.2.3 Terumo Corporation Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Terumo Corporation Main Business Overview
13.2.5 Terumo Corporation Latest Developments
13.3 Stryker Corporation
13.3.1 Stryker Corporation Company Information
13.3.2 Stryker Corporation Drug–Device Combination Products Product Portfolios and Specifications
13.3.3 Stryker Corporation Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Stryker Corporation Main Business Overview
13.3.5 Stryker Corporation Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Drug–Device Combination Products Product Portfolios and Specifications
13.4.3 Mylan Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Medtronic
13.5.1 Medtronic Company Information
13.5.2 Medtronic Drug–Device Combination Products Product Portfolios and Specifications
13.5.3 Medtronic Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Medtronic Main Business Overview
13.5.5 Medtronic Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Drug–Device Combination Products Product Portfolios and Specifications
13.6.3 Allergan Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Boston Scientific
13.7.1 Boston Scientific Company Information
13.7.2 Boston Scientific Drug–Device Combination Products Product Portfolios and Specifications
13.7.3 Boston Scientific Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boston Scientific Main Business Overview
13.7.5 Boston Scientific Latest Developments
13.8 Novartis
13.8.1 Novartis Company Information
13.8.2 Novartis Drug–Device Combination Products Product Portfolios and Specifications
13.8.3 Novartis Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novartis Main Business Overview
13.8.5 Novartis Latest Developments
13.9 BD
13.9.1 BD Company Information
13.9.2 BD Drug–Device Combination Products Product Portfolios and Specifications
13.9.3 BD Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BD Main Business Overview
13.9.5 BD Latest Developments
13.10 Teleflex Incorporated
13.10.1 Teleflex Incorporated Company Information
13.10.2 Teleflex Incorporated Drug–Device Combination Products Product Portfolios and Specifications
13.10.3 Teleflex Incorporated Drug–Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teleflex Incorporated Main Business Overview
13.10.5 Teleflex Incorporated Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug–Device Combination Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug–Device Combination Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Infusion Pumps
Table 4. Major Players of Orthopedic Combination Products
Table 5. Major Players of Photodynamic Therapy Devices
Table 6. Major Players of Transdermal Patches
Table 7. Major Players of Drug Eluting Stents
Table 8. Major Players of Wound Care Products
Table 9. Major Players of Inhalers
Table 10. Major Players of Other
Table 11. Global Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 12. Global Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Table 13. Global Drug–Device Combination Products Revenue by Type (2018-2023) & ($ million)
Table 14. Global Drug–Device Combination Products Revenue Market Share by Type (2018-2023)
Table 15. Global Drug–Device Combination Products Sale Price by Type (2018-2023) & (USD/Unit)
Table 16. Global Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 17. Global Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Table 18. Global Drug–Device Combination Products Revenue by Application (2018-2023)
Table 19. Global Drug–Device Combination Products Revenue Market Share by Application (2018-2023)
Table 20. Global Drug–Device Combination Products Sale Price by Application (2018-2023) & (USD/Unit)
Table 21. Global Drug–Device Combination Products Sales by Company (2018-2023) & (K Units)
Table 22. Global Drug–Device Combination Products Sales Market Share by Company (2018-2023)
Table 23. Global Drug–Device Combination Products Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Drug–Device Combination Products Revenue Market Share by Company (2018-2023)
Table 25. Global Drug–Device Combination Products Sale Price by Company (2018-2023) & (USD/Unit)
Table 26. Key Manufacturers Drug–Device Combination Products Producing Area Distribution and Sales Area
Table 27. Players Drug–Device Combination Products Products Offered
Table 28. Drug–Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Drug–Device Combination Products Sales by Geographic Region (2018-2023) & (K Units)
Table 32. Global Drug–Device Combination Products Sales Market Share Geographic Region (2018-2023)
Table 33. Global Drug–Device Combination Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Drug–Device Combination Products Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Drug–Device Combination Products Sales by Country/Region (2018-2023) & (K Units)
Table 36. Global Drug–Device Combination Products Sales Market Share by Country/Region (2018-2023)
Table 37. Global Drug–Device Combination Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Drug–Device Combination Products Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Drug–Device Combination Products Sales by Country (2018-2023) & (K Units)
Table 40. Americas Drug–Device Combination Products Sales Market Share by Country (2018-2023)
Table 41. Americas Drug–Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Drug–Device Combination Products Revenue Market Share by Country (2018-2023)
Table 43. Americas Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 44. Americas Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 45. APAC Drug–Device Combination Products Sales by Region (2018-2023) & (K Units)
Table 46. APAC Drug–Device Combination Products Sales Market Share by Region (2018-2023)
Table 47. APAC Drug–Device Combination Products Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Drug–Device Combination Products Revenue Market Share by Region (2018-2023)
Table 49. APAC Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 50. APAC Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 51. Europe Drug–Device Combination Products Sales by Country (2018-2023) & (K Units)
Table 52. Europe Drug–Device Combination Products Sales Market Share by Country (2018-2023)
Table 53. Europe Drug–Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Drug–Device Combination Products Revenue Market Share by Country (2018-2023)
Table 55. Europe Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 56. Europe Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 57. Middle East & Africa Drug–Device Combination Products Sales by Country (2018-2023) & (K Units)
Table 58. Middle East & Africa Drug–Device Combination Products Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Drug–Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Drug–Device Combination Products Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 62. Middle East & Africa Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 63. Key Market Drivers & Growth Opportunities of Drug–Device Combination Products
Table 64. Key Market Challenges & Risks of Drug–Device Combination Products
Table 65. Key Industry Trends of Drug–Device Combination Products
Table 66. Drug–Device Combination Products Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Drug–Device Combination Products Distributors List
Table 69. Drug–Device Combination Products Customer List
Table 70. Global Drug–Device Combination Products Sales Forecast by Region (2024-2029) & (K Units)
Table 71. Global Drug–Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Drug–Device Combination Products Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Americas Drug–Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Drug–Device Combination Products Sales Forecast by Region (2024-2029) & (K Units)
Table 75. APAC Drug–Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Drug–Device Combination Products Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Europe Drug–Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Drug–Device Combination Products Sales Forecast by Country (2024-2029) & (K Units)
Table 79. Middle East & Africa Drug–Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Drug–Device Combination Products Sales Forecast by Type (2024-2029) & (K Units)
Table 81. Global Drug–Device Combination Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Drug–Device Combination Products Sales Forecast by Application (2024-2029) & (K Units)
Table 83. Global Drug–Device Combination Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Abbott Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Abbott Drug–Device Combination Products Product Portfolios and Specifications
Table 86. Abbott Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Abbott Main Business
Table 88. Abbott Latest Developments
Table 89. Terumo Corporation Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Terumo Corporation Drug–Device Combination Products Product Portfolios and Specifications
Table 91. Terumo Corporation Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Terumo Corporation Main Business
Table 93. Terumo Corporation Latest Developments
Table 94. Stryker Corporation Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Stryker Corporation Drug–Device Combination Products Product Portfolios and Specifications
Table 96. Stryker Corporation Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Stryker Corporation Main Business
Table 98. Stryker Corporation Latest Developments
Table 99. Mylan Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Drug–Device Combination Products Product Portfolios and Specifications
Table 101. Mylan Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Medtronic Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Medtronic Drug–Device Combination Products Product Portfolios and Specifications
Table 106. Medtronic Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Medtronic Main Business
Table 108. Medtronic Latest Developments
Table 109. Allergan Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 110. Allergan Drug–Device Combination Products Product Portfolios and Specifications
Table 111. Allergan Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Allergan Main Business
Table 113. Allergan Latest Developments
Table 114. Boston Scientific Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 115. Boston Scientific Drug–Device Combination Products Product Portfolios and Specifications
Table 116. Boston Scientific Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Boston Scientific Main Business
Table 118. Boston Scientific Latest Developments
Table 119. Novartis Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Drug–Device Combination Products Product Portfolios and Specifications
Table 121. Novartis Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. BD Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 125. BD Drug–Device Combination Products Product Portfolios and Specifications
Table 126. BD Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. BD Main Business
Table 128. BD Latest Developments
Table 129. Teleflex Incorporated Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 130. Teleflex Incorporated Drug–Device Combination Products Product Portfolios and Specifications
Table 131. Teleflex Incorporated Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Teleflex Incorporated Main Business
Table 133. Teleflex Incorporated Latest Developments
Table 1. Drug–Device Combination Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug–Device Combination Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Infusion Pumps
Table 4. Major Players of Orthopedic Combination Products
Table 5. Major Players of Photodynamic Therapy Devices
Table 6. Major Players of Transdermal Patches
Table 7. Major Players of Drug Eluting Stents
Table 8. Major Players of Wound Care Products
Table 9. Major Players of Inhalers
Table 10. Major Players of Other
Table 11. Global Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 12. Global Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Table 13. Global Drug–Device Combination Products Revenue by Type (2018-2023) & ($ million)
Table 14. Global Drug–Device Combination Products Revenue Market Share by Type (2018-2023)
Table 15. Global Drug–Device Combination Products Sale Price by Type (2018-2023) & (USD/Unit)
Table 16. Global Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 17. Global Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Table 18. Global Drug–Device Combination Products Revenue by Application (2018-2023)
Table 19. Global Drug–Device Combination Products Revenue Market Share by Application (2018-2023)
Table 20. Global Drug–Device Combination Products Sale Price by Application (2018-2023) & (USD/Unit)
Table 21. Global Drug–Device Combination Products Sales by Company (2018-2023) & (K Units)
Table 22. Global Drug–Device Combination Products Sales Market Share by Company (2018-2023)
Table 23. Global Drug–Device Combination Products Revenue by Company (2018-2023) ($ Millions)
Table 24. Global Drug–Device Combination Products Revenue Market Share by Company (2018-2023)
Table 25. Global Drug–Device Combination Products Sale Price by Company (2018-2023) & (USD/Unit)
Table 26. Key Manufacturers Drug–Device Combination Products Producing Area Distribution and Sales Area
Table 27. Players Drug–Device Combination Products Products Offered
Table 28. Drug–Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Drug–Device Combination Products Sales by Geographic Region (2018-2023) & (K Units)
Table 32. Global Drug–Device Combination Products Sales Market Share Geographic Region (2018-2023)
Table 33. Global Drug–Device Combination Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 34. Global Drug–Device Combination Products Revenue Market Share by Geographic Region (2018-2023)
Table 35. Global Drug–Device Combination Products Sales by Country/Region (2018-2023) & (K Units)
Table 36. Global Drug–Device Combination Products Sales Market Share by Country/Region (2018-2023)
Table 37. Global Drug–Device Combination Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 38. Global Drug–Device Combination Products Revenue Market Share by Country/Region (2018-2023)
Table 39. Americas Drug–Device Combination Products Sales by Country (2018-2023) & (K Units)
Table 40. Americas Drug–Device Combination Products Sales Market Share by Country (2018-2023)
Table 41. Americas Drug–Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 42. Americas Drug–Device Combination Products Revenue Market Share by Country (2018-2023)
Table 43. Americas Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 44. Americas Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 45. APAC Drug–Device Combination Products Sales by Region (2018-2023) & (K Units)
Table 46. APAC Drug–Device Combination Products Sales Market Share by Region (2018-2023)
Table 47. APAC Drug–Device Combination Products Revenue by Region (2018-2023) & ($ Millions)
Table 48. APAC Drug–Device Combination Products Revenue Market Share by Region (2018-2023)
Table 49. APAC Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 50. APAC Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 51. Europe Drug–Device Combination Products Sales by Country (2018-2023) & (K Units)
Table 52. Europe Drug–Device Combination Products Sales Market Share by Country (2018-2023)
Table 53. Europe Drug–Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 54. Europe Drug–Device Combination Products Revenue Market Share by Country (2018-2023)
Table 55. Europe Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 56. Europe Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 57. Middle East & Africa Drug–Device Combination Products Sales by Country (2018-2023) & (K Units)
Table 58. Middle East & Africa Drug–Device Combination Products Sales Market Share by Country (2018-2023)
Table 59. Middle East & Africa Drug–Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 60. Middle East & Africa Drug–Device Combination Products Revenue Market Share by Country (2018-2023)
Table 61. Middle East & Africa Drug–Device Combination Products Sales by Type (2018-2023) & (K Units)
Table 62. Middle East & Africa Drug–Device Combination Products Sales by Application (2018-2023) & (K Units)
Table 63. Key Market Drivers & Growth Opportunities of Drug–Device Combination Products
Table 64. Key Market Challenges & Risks of Drug–Device Combination Products
Table 65. Key Industry Trends of Drug–Device Combination Products
Table 66. Drug–Device Combination Products Raw Material
Table 67. Key Suppliers of Raw Materials
Table 68. Drug–Device Combination Products Distributors List
Table 69. Drug–Device Combination Products Customer List
Table 70. Global Drug–Device Combination Products Sales Forecast by Region (2024-2029) & (K Units)
Table 71. Global Drug–Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Americas Drug–Device Combination Products Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Americas Drug–Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. APAC Drug–Device Combination Products Sales Forecast by Region (2024-2029) & (K Units)
Table 75. APAC Drug–Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 76. Europe Drug–Device Combination Products Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Europe Drug–Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Middle East & Africa Drug–Device Combination Products Sales Forecast by Country (2024-2029) & (K Units)
Table 79. Middle East & Africa Drug–Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 80. Global Drug–Device Combination Products Sales Forecast by Type (2024-2029) & (K Units)
Table 81. Global Drug–Device Combination Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 82. Global Drug–Device Combination Products Sales Forecast by Application (2024-2029) & (K Units)
Table 83. Global Drug–Device Combination Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 84. Abbott Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Abbott Drug–Device Combination Products Product Portfolios and Specifications
Table 86. Abbott Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Abbott Main Business
Table 88. Abbott Latest Developments
Table 89. Terumo Corporation Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Terumo Corporation Drug–Device Combination Products Product Portfolios and Specifications
Table 91. Terumo Corporation Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Terumo Corporation Main Business
Table 93. Terumo Corporation Latest Developments
Table 94. Stryker Corporation Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Stryker Corporation Drug–Device Combination Products Product Portfolios and Specifications
Table 96. Stryker Corporation Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Stryker Corporation Main Business
Table 98. Stryker Corporation Latest Developments
Table 99. Mylan Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Drug–Device Combination Products Product Portfolios and Specifications
Table 101. Mylan Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Medtronic Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Medtronic Drug–Device Combination Products Product Portfolios and Specifications
Table 106. Medtronic Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Medtronic Main Business
Table 108. Medtronic Latest Developments
Table 109. Allergan Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 110. Allergan Drug–Device Combination Products Product Portfolios and Specifications
Table 111. Allergan Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Allergan Main Business
Table 113. Allergan Latest Developments
Table 114. Boston Scientific Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 115. Boston Scientific Drug–Device Combination Products Product Portfolios and Specifications
Table 116. Boston Scientific Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Boston Scientific Main Business
Table 118. Boston Scientific Latest Developments
Table 119. Novartis Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Drug–Device Combination Products Product Portfolios and Specifications
Table 121. Novartis Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. BD Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 125. BD Drug–Device Combination Products Product Portfolios and Specifications
Table 126. BD Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. BD Main Business
Table 128. BD Latest Developments
Table 129. Teleflex Incorporated Basic Information, Drug–Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 130. Teleflex Incorporated Drug–Device Combination Products Product Portfolios and Specifications
Table 131. Teleflex Incorporated Drug–Device Combination Products Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Teleflex Incorporated Main Business
Table 133. Teleflex Incorporated Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug–Device Combination Products
Figure 2. Drug–Device Combination Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug–Device Combination Products Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug–Device Combination Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug–Device Combination Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Infusion Pumps
Figure 10. Product Picture of Orthopedic Combination Products
Figure 11. Product Picture of Photodynamic Therapy Devices
Figure 12. Product Picture of Transdermal Patches
Figure 13. Product Picture of Drug Eluting Stents
Figure 14. Product Picture of Wound Care Products
Figure 15. Product Picture of Inhalers
Figure 16. Product Picture of Other
Figure 17. Global Drug–Device Combination Products Sales Market Share by Type in 2022
Figure 18. Global Drug–Device Combination Products Revenue Market Share by Type (2018-2023)
Figure 19. Drug–Device Combination Products Consumed in Hospital
Figure 20. Global Drug–Device Combination Products Market: Hospital (2018-2023) & (K Units)
Figure 21. Drug–Device Combination Products Consumed in Clinic
Figure 22. Global Drug–Device Combination Products Market: Clinic (2018-2023) & (K Units)
Figure 23. Drug–Device Combination Products Consumed in Other
Figure 24. Global Drug–Device Combination Products Market: Other (2018-2023) & (K Units)
Figure 25. Global Drug–Device Combination Products Sales Market Share by Application (2022)
Figure 26. Global Drug–Device Combination Products Revenue Market Share by Application in 2022
Figure 27. Drug–Device Combination Products Sales Market by Company in 2022 (K Units)
Figure 28. Global Drug–Device Combination Products Sales Market Share by Company in 2022
Figure 29. Drug–Device Combination Products Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Drug–Device Combination Products Revenue Market Share by Company in 2022
Figure 31. Global Drug–Device Combination Products Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Drug–Device Combination Products Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 34. Americas Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 35. APAC Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 36. APAC Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 37. Europe Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 38. Europe Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 41. Americas Drug–Device Combination Products Sales Market Share by Country in 2022
Figure 42. Americas Drug–Device Combination Products Revenue Market Share by Country in 2022
Figure 43. Americas Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 44. Americas Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 45. United States Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Drug–Device Combination Products Sales Market Share by Region in 2022
Figure 50. APAC Drug–Device Combination Products Revenue Market Share by Regions in 2022
Figure 51. APAC Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 52. APAC Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 53. China Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Drug–Device Combination Products Sales Market Share by Country in 2022
Figure 61. Europe Drug–Device Combination Products Revenue Market Share by Country in 2022
Figure 62. Europe Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 63. Europe Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 64. Germany Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Drug–Device Combination Products Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Drug–Device Combination Products Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 73. Egypt Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Drug–Device Combination Products in 2022
Figure 79. Manufacturing Process Analysis of Drug–Device Combination Products
Figure 80. Industry Chain Structure of Drug–Device Combination Products
Figure 81. Channels of Distribution
Figure 82. Global Drug–Device Combination Products Sales Market Forecast by Region (2024-2029)
Figure 83. Global Drug–Device Combination Products Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Drug–Device Combination Products Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Drug–Device Combination Products Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Drug–Device Combination Products Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Drug–Device Combination Products Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Drug–Device Combination Products
Figure 2. Drug–Device Combination Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug–Device Combination Products Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug–Device Combination Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug–Device Combination Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Infusion Pumps
Figure 10. Product Picture of Orthopedic Combination Products
Figure 11. Product Picture of Photodynamic Therapy Devices
Figure 12. Product Picture of Transdermal Patches
Figure 13. Product Picture of Drug Eluting Stents
Figure 14. Product Picture of Wound Care Products
Figure 15. Product Picture of Inhalers
Figure 16. Product Picture of Other
Figure 17. Global Drug–Device Combination Products Sales Market Share by Type in 2022
Figure 18. Global Drug–Device Combination Products Revenue Market Share by Type (2018-2023)
Figure 19. Drug–Device Combination Products Consumed in Hospital
Figure 20. Global Drug–Device Combination Products Market: Hospital (2018-2023) & (K Units)
Figure 21. Drug–Device Combination Products Consumed in Clinic
Figure 22. Global Drug–Device Combination Products Market: Clinic (2018-2023) & (K Units)
Figure 23. Drug–Device Combination Products Consumed in Other
Figure 24. Global Drug–Device Combination Products Market: Other (2018-2023) & (K Units)
Figure 25. Global Drug–Device Combination Products Sales Market Share by Application (2022)
Figure 26. Global Drug–Device Combination Products Revenue Market Share by Application in 2022
Figure 27. Drug–Device Combination Products Sales Market by Company in 2022 (K Units)
Figure 28. Global Drug–Device Combination Products Sales Market Share by Company in 2022
Figure 29. Drug–Device Combination Products Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Drug–Device Combination Products Revenue Market Share by Company in 2022
Figure 31. Global Drug–Device Combination Products Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Drug–Device Combination Products Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 34. Americas Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 35. APAC Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 36. APAC Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 37. Europe Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 38. Europe Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Drug–Device Combination Products Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Drug–Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 41. Americas Drug–Device Combination Products Sales Market Share by Country in 2022
Figure 42. Americas Drug–Device Combination Products Revenue Market Share by Country in 2022
Figure 43. Americas Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 44. Americas Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 45. United States Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Drug–Device Combination Products Sales Market Share by Region in 2022
Figure 50. APAC Drug–Device Combination Products Revenue Market Share by Regions in 2022
Figure 51. APAC Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 52. APAC Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 53. China Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Drug–Device Combination Products Sales Market Share by Country in 2022
Figure 61. Europe Drug–Device Combination Products Revenue Market Share by Country in 2022
Figure 62. Europe Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 63. Europe Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 64. Germany Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Drug–Device Combination Products Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Drug–Device Combination Products Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Drug–Device Combination Products Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Drug–Device Combination Products Sales Market Share by Application (2018-2023)
Figure 73. Egypt Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Drug–Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Drug–Device Combination Products in 2022
Figure 79. Manufacturing Process Analysis of Drug–Device Combination Products
Figure 80. Industry Chain Structure of Drug–Device Combination Products
Figure 81. Channels of Distribution
Figure 82. Global Drug–Device Combination Products Sales Market Forecast by Region (2024-2029)
Figure 83. Global Drug–Device Combination Products Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Drug–Device Combination Products Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Drug–Device Combination Products Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Drug–Device Combination Products Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Drug–Device Combination Products Revenue Market Share Forecast by Application (2024-2029)
